Navigation Links
Now, a Hormone-free Contraceptive Pill for Men

British scientists have developed a hormone-free contraceptive pill for men they say would make them infertile for some hours.//

The tablet, developed by researched at King's College London, can be taken hours before sex and would prevent a man from being able to impregnate a woman. However, his fertility would return to normal within a few hours, reported the online edition of Daily Mail.

Contraceptive pills available in the market now are only for the exclusive use of women. Annual worldwide sales of these female pills are worth 21 billion pounds.

Currently men who want to take responsibility for contraception have limited choice with their options extending to condoms, vasectomy or simple abstinence.

The new pill developed by Nnaemeka Amobi and other researchers would be more likely to be trusted by women because they are not relying on their man having to remember to take his pill every day for it to work.

Experts believe it could transform family planning by allowing couples to share the responsibility for contraception - a role that traditionally falls on women.

John Guillebaud, one of Britain's leading experts on contraception, described the pill as "a brilliant discovery".

He said its strength lay in its ability to prevent pregnancy without using hormones, which could cause side effects such as hot flushes and moodiness.

Other male pills are under development but many of them are based on hormones that trick the brain into switching off sperm production. These are typically being developed as injections, implants and patches.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Contraceptives via Internet
2. FDA Approves Contraceptive Ring
3. Contraceptives decreases Libido
4. Contraceptives have dual effects
5. Drugs For Anthrax May Interfere With Oral Contraceptives
6. Contraceptive pill to reduce PMS
7. Smoking and Oral Contraceptives:
8. Contraceptive pills may lead to deformities in babies
9. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
10. Prevent Multiple Sclerosis From Oral Contraceptives
11. Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients
Post Your Comments:
Breaking Medicine News(10 mins):Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 3Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 2Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 4Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 2Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 3Health News:Sticks and stones break bones, but this UH study may prevent it 2
Other Medicine Technology:Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 2Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 3Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 3Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 5Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 6